Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |